Canadian developer of vertically integrated functional mushroom Optimi Health Corp. (CNSX: OPTI) announced having received NPN product licensing in Canada. This gives the company a green light to start marketing and selling nutraceuticals in the second quarter of the year.
The company has been developing medicinal and nutraceutical mushroom brands including natural health products to come up with proposed future psychedelic formulations.
Optimi Health had applied licenses for six NPN products which include five singular mushroom strain capsules namely; Turkey Tail, Chaga, Lions Mane, Cordyceps and Reishi and One mixed blend capsule.
All the six products were granted licenses by the regulators. If one is interested in selling health products in Canada, they must first secure a product license called a Natural Product Number (NPN).
This license is given by the Natural and Non-Prescription Health Product Directorate (NNHPD) of Health Canada after the regulator has assessed the products. The license comes with a 8 digit pin which must always be shown on brand packaging.
Following the approval, Optimi Health now is aiming at cultivating and extracting dried mushrooms from its own facilities. Construction of the facilities in Princeton is currently on going and the company is expecting the project to be through in the second quarter of the year.
